A group of researchers have discovered that even 20 years after a diagnosis, women ER-positive breast cancer still face a substantial risk of cancer returning or spreading. The study could influence decisions about long-term therapy.
Browsing: emerging therapies
Circumvent hesitancy between CDK4/6 and mTOR inhibitors in second-line treatment of HR+, erb2- metastatic breast cancer
In this editorial from Future Oncology the authors explore tumor biology, host biology and patient’s quality of life in respect to circumvent hesitancy between CDK4/6 and mTOR inhibitors in second-line treatment of HR+, erb2- metastatic breast cancer.
Researchers at the University of North Carolina Lineberger Comprehensive Cancer Center (NC, USA) are developing a potential new immunotherapy strategy for melanoma.
The roll out of more effective and affordable screening programes alongside advancements in treatment options…
What is the potential clinical significance of the results of the FLAURA trial presented at ESMO? Find out in our exclusive interview.
Chris was diagnosed with lymphoma in 2007, as part of his treatment he received a stem cell transplant – in this video you can discover what it is like to undergo a stem cell transplant and find out how it is performed.
Proper staging, early detection and accurate diagnosis all play a key role in successful treatment for cancer patients. Discover some of the treatment options for mesothelioma in this opinion piece.
We spoke with a key study investigator of the multiple myeloma ENDEAVOR trial to explore the trial in more detail and to discover the potential clinical application of its overall survival findings.
Results from two international clinical trials yield promising results for halting the mestatise of melanoma, yield novel treatment options for melanoma and may help stop this form of cancer metastizing.
A recent clinical trial presents new data indicating durvalumab improves progression-free survival in patients with stage III non-small-cell lung cancer (NSCLC).